BP Immediate Medical Care, PC
BP Immediate Medical Care, PC was paid $45.09M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoBP IMMEDIATE MEDICAL CARE, PC
BROOKLYN, NY 11218
BROOKLYN, NY 11218
33aNPI1205105004assigned 12/22/2011
33bProvider typeSpecialist
28Total paid$45.09M
24GClaims919,699
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#4 of 1,221
Median peer was paid$45K
This provider vs. median997×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,145 | $3.33M | |
| 2019 | 88,431 | $4.23M | |
| 2020 | 165,191 | $8.16M | |
| 2021 | 198,512 | $10.03M | |
| 2022 | 140,245 | $6.45M | |
| 2023 | 161,069 | $7.50M | |
| 2024incomplete | 110,106 | $5.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 193,294 | 173,036 | $13.99M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 21% | 108,759 | 107,330 | $9.38M |
| S9083 | Global fee urgent care centers | 18% | 81,536 | 72,495 | $8.04M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.4% | 43,134 | 40,632 | $3.79M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.5% | 32,568 | 29,848 | $2.46M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.0% | 67,446 | 61,549 | $1.81M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.4% | 14,764 | 14,670 | $1.54M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.2% | 22,940 | 20,871 | $991K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.8% | 12,877 | 12,799 | $819K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 106,480 | 100,303 | $615K |
| 99441 | 1.3% | 11,822 | 11,012 | $586K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 21,546 | 10,974 | $186K |
79 more codes
| 87070 | <1% | 25,404 | $164K | |
| 87276 | <1% | 7,165 | $60K | |
| 87275 | <1% | 7,132 | $58K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,452 | $48K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 185 | $46K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,626 | $39K |
| 12001 | <1% | 634 | $38K | |
| 99050 | <1% | 7,693 | $34K | |
| 73630 | <1% | 2,587 | $29K | |
| 29125 | <1% | 727 | $28K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,980 | $26K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 466 | $24K |
| 73110 | <1% | 1,814 | $24K | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 605 | $19K |
| 73130 | <1% | 1,373 | $18K | |
| 99442 | <1% | 204 | $18K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,096 | $15K |
| 73610 | <1% | 1,262 | $15K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,670 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 298 | $12K |
| 96127 | <1% | 6,703 | $11K | |
| 90686 | <1% | 666 | $11K | |
| 29130 | <1% | 546 | $10K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 604 | $10K |
| 90658 | <1% | 692 | $9K | |
| 0011A | <1% | 185 | $8K | |
| Q4049 | Finger splint, static | <1% | 267 | $7K |
| 81002 | <1% | 5,344 | $6K | |
| 73140 | <1% | 839 | $6K | |
| 93000 | <1% | 543 | $6K | |
| 99051 | <1% | 9,389 | $5K | |
| 12011 | <1% | 66 | $5K | |
| 81025 | <1% | 2,978 | $5K | |
| 99000 | <1% | 18,922 | $5K | |
| 99072 | <1% | 5,848 | $5K | |
| 25600 | <1% | 34 | $5K | |
| 0012A | <1% | 71 | $4K | |
| 99001 | <1% | 37,553 | $4K | |
| 73080 | <1% | 288 | $4K | |
| 10121 | <1% | 17 | $3K | |
| 10060 | <1% | 71 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 481 | $3K |
| 10120 | <1% | 40 | $3K | |
| 0002A | <1% | 52 | $2K | |
| 69210 | <1% | 102 | $2K | |
| 0001A | <1% | 40 | $2K | |
| 0031A | <1% | 44 | $2K | |
| 90688 | <1% | 539 | $2K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 7,127 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 115 | $1K |
| 73090 | <1% | 128 | $1K | |
| 73562 | <1% | 87 | $943.87 | |
| 73590 | <1% | 56 | $734.25 | |
| 99443 | <1% | 416 | $404.65 | |
| 0013A | <1% | 18 | $313.35 | |
| S8431 | Compression bandage, roll | <1% | 65 | $297.50 |
| 87807 | <1% | 13 | $264.30 | |
| 86618 | <1% | 12 | $238.47 | |
| 90715 | <1% | 12 | $233.62 | |
| 82962 | <1% | 92 | $231.40 | |
| 80305 | <1% | 34 | $175.82 | |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | <1% | 13 | $123.20 |
| 85027 | <1% | 24 | $115.20 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 19 | $104.24 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 26 | $86.80 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $59.61 |
| 90694 | <1% | 28 | $30.50 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 16 | $26.46 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16 | $26.45 |
| 1125F | <1% | 11,332 | $9.01 | |
| 1160F | <1% | 9,283 | $1.00 | |
| 1126F | <1% | 454 | $1.00 | |
| 1159F | 0% | 758 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 164 | $0.00 |
| 99080 | 0% | 61 | $0.00 | |
| A4565 | Slings | 0% | 35 | $0.00 |
| 3008F | 0% | 708 | $0.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 40 | $0.00 |
| 71020 | 0% | 71 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWERZBERGER, SAMUEL (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Friendly Urgent Care, LLC | Teaneck, NJ | $8.65M |
| Urgent Care Medical Associates Professional Corporation | Dover, NJ | $5K |
| New Health Medical New York PC | Brooklyn, NY | $302.27 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.